Issuance of Stock Acquisition Rights to Directors and Employees
First written in FY2017-Q2. 13 of 16 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2024.
- FY2024DroppedAnnual report
「Stock options had previously involved the annual free issuance of stock acquisition rights at a fixed time each year. However, at the Board of Directors meeting held on 25 April 2024, it was resolved that no new stock acquisition rights would be issued as stock options from FY2024 onward.」
Although employee stock acquisition rights remain outstanding through the 2023 issuance, a policy has been explicitly stated not to issue any new rights from fiscal 2024 onward. - FY2024-Q3Decrease in outstanding stock acquisition rights and no new issuanceAnnual report
「① [Stock Option Plan Details] There are no applicable items. ② [Status of Other Stock Acquisition Rights, etc.] There are no applicable items. Stock acquisition rights 134 108」
No new issuance of stock acquisition rights during the third-quarter accounting period is indicated. Stock acquisition rights on the balance sheet decreased from ¥134 million at the end of the previous consolidated fiscal year to ¥108 million. - FY2024-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Number of stock acquisition rights (units)* 2,520 (Note 1) Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 252,000 (Note 2) Exercise period of stock acquisition rights* 1 August 2025– 31 July 2028」
Based on the resolution of 16 June 2023, 2,520 stock acquisition rights covering 252,000 shares were issued for directors, executive officers, subsidiary officers and employees, with an exercise period from August 2025 to July 2028. - FY2023-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Number of stock acquisition rights (units)* 2,890 (Note 1) Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 289,000 (Note 2) Exercise period of stock acquisition rights* 1 August 2024– 31 July 2027」
Based on the resolution of 17 June 2022, 2,890 stock acquisition rights covering 289,000 shares were issued for directors, executive officers, subsidiary officers and employees, with an exercise period from August 2024 to July 2027. - FY2022-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
Based on the resolution of 15 June 2021, 2,840 stock acquisition rights covering 284,000 shares were issued for directors, executive officers, subsidiary officers and employees. The exercise period runs from 1 August 2023 to 31 July 2026. - FY2021-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
Based on the resolution of 9 June 2020, 2,920 stock acquisition rights covering 292,000 shares were issued on 7 August 2020 for officers, employees and others, with an exercise period from 1 August 2022 to 31 July 2025. - FY2020-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
Based on the resolution of 11 June 2019, 2,990 stock acquisition rights covering 299,000 shares were issued on 7 August 2019 for officers, employees and others, with an exercise period from 1 August 2021 to 31 July 2024. - FY2019AdvancedAnnual report
「1 April 2018–31 March 2019 (Note) 1. Issuance of new shares (exercise of stock acquisition rights) Increase from the exercise of stock options: 51,000 shares」
During the fiscal year, 51,000 shares were issued through the exercise of stock options, increasing stated capital and capital surplus by ¥33 million each. In addition, based on the resolution of 11 June 2019, a new grant pool covering up to 310,000 shares was established, with an exercise period from 1 August 2021 to 31 July 2024. - FY2019-Q2AdvancedAnnual report
「1 July 2018– 30 September 2018 (Note) 25,000 29,172,457 15 6,712 15 10,342 (Note) These increases resulted from the exercise of stock acquisition rights.」
During the second-quarter accounting period, 25,000 shares were added through the exercise of stock acquisition rights, increasing stated capital and capital surplus by ¥15 million each. - FY2019-Q1AdvancedAnnual report
「1 April 2018– 30 June 2018 (Note) 26,000 29,147,457 17 6,696 17 10,326 (Note) These increases resulted from the exercise of stock acquisition rights.」
During the first quarter, 26,000 shares were added through the exercise of stock acquisition rights, increasing stated capital and capital surplus by ¥17 million each. - FY2018AdvancedAnnual report
「1 April 2017–31 March 2018 (Note) 1. Issuance of new shares (exercise of stock acquisition rights) Increase from the exercise of stock options: 52,000 shares」
52,000 shares were issued during the fiscal year through the exercise of stock acquisition rights. In addition, based on the resolution of 12 June 2018, a new grant pool covering up to 290,000 shares was established, with an exercise period from 1 August 2020 to 31 July 2023. - FY2018-Q3AdvancedAnnual report
「1 October 2017– 31 December 2017 (Note) 1. 26,000 29,111,457 23 6,670 23 10,300 (Note) 1. These increases resulted from the exercise of stock acquisition rights. 2. From 1 January 2018 to 31 January 2018, the exercise of stock acquisition rights increased the total number of issued shares by 7,000 and increased stated capital and capital surplus by ¥6 million each.」
During the third-quarter accounting period, 26,000 shares were added through the exercise of stock acquisition rights, and a further 7,000 shares were added in January 2018 before the filing date. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Number of stock acquisition rights (units): 3,110 (Note 1); number of shares underlying the stock acquisition rights (shares): 311,000 (Note 2); exercise period: 1 August 2019 to 31 July 2022」
3,110 stock acquisition rights covering 311,000 shares were newly issued for officers, employees and others, with an exercise period from August 2019 to July 2022. - FY2017AdvancedAnnual report
「1 April 2016–31 March 2017 (Note) 1. Issuance of new shares (exercise of stock acquisition rights) Increase from the exercise of stock options: 225,000 shares」
225,000 shares were issued during the fiscal year through the exercise of stock options for officers and employees. The figure has been updated from 181,000 shares through the third quarter to the full-year result. - FY2017-Q3AdvancedAnnual report
「Increase in total number of issued shares: 181,000; increase in stated capital: 125; increase in capital surplus: 125. These increases resulted from the exercise of stock acquisition rights.」
During the third quarter, 181,000 shares were issued through the exercise of stock acquisition rights issued in the second quarter, increasing stated capital and capital surplus by ¥125 million each. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Number of stock acquisition rights (units): 2,700; number of shares underlying the stock acquisition rights (shares): 270,000; exercise period: 1 August 2018 to 31 July 2021」
2,700 stock acquisition rights were issued for directors, executive officers, employees and others, covering 270,000 shares. The exercise period runs from 1 August 2018 to 31 July 2021.